The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
Premium- After receiving word from the FDA that lead hepatitis C (HCV) treatment candidate, IDX-184, was placed on partial clinical hold as of mid-August, Idenix Pharmaceuticals … Continue Reading
Read nowQuick Picks - Genzyme, a subsidiary of Sanofi (NYSE:SNY), announced this morning that the FDA has returned the company’s supplemental Biologics License Application (sBLA) for Lemtrada on grounds … Continue Reading
Read now- Immunogen’s (NASDAQ: IMGN) partner, Roche Holdings (OTC:RHHBY), reported new data from a Phase III  trial, demonstrating that trastuzumab emtansine (T-DM1), which leverages technology from IMGN, … Continue Reading
Read nowQuick Picks - Watson Pharmaceuticals (NYSE:WPI) announced today that the FDA has approved the company’s generic version of Lidoderm, a skin patch that delivers the painkiller lidocaine currently … Continue Reading
Read nowQuick Picks - Oncothyreon (NASDAQ:ONTY) is up 11% this morning after a major gap from yesterday’s close took shares to $4.94. The jump comes on the heels of … Continue Reading
Read nowLong Ideas - Eli Lilly & Co. (NYSE:LLY) announced this morning that its potential treatment to slow the onset of Alzheimer’s Disease, solanezumab, showed favorable effects in its … Continue Reading
Read nowQuick Picks - Bristol-Myer’s Squibb (NYSE:BMY) announced last night that it would be officially discontinuing development of its Hepatitis C treatment, known as BMS-986094, and revealed the financial … Continue Reading
Read now
